CBX2 Polyclonal Antibody
Applications
Reactivity
| Overview | |
| Catalog # | bs-53083R-100uL |
| Product Name | CBX2 Polyclonal Antibody |
| Applications |
ELISA
|
| Reactivity | Mouse |
| Specifications | |
| Conjugation | Unconjugated |
| Host | Rabbit |
| Source | Polyclonal antibody raised in rabbit against mouse CBX2 (chromobox homolog 2) using two KLH-conjugated synthetic peptides containing a sequence from the central region of the protein |
| Clonality | Polyclonal |
| Isotype | Not Determined |
| Concentration | Not Determined |
| Purification | Whole antiserum from rabbit containing 0.05% azide |
| Storage Buffer | 0.01M TBS(pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol. |
| Storage Condition | Store at -20C for 12 months. |
| Target | |
| Gene ID | 84733 |
| Swiss Prot | Q14781 |
| Synonyms | Chromobox protein homolog 2, CBX2 |
| Background | Component of a Polycomb group (PcG) multiprotein PRC1-like complex, a complex class required to maintain the transcriptionally repressive state of many genes, including Hox genes, throughout development. PcG PRC1 complex acts via chromatin remodeling and modification of histones; it mediates monoubiquitination of histone H2A 'Lys-119', rendering chromatin heritably changed in its expressibility. Involved in sexual development, acting as activator of NR5A1 expression. |
| Application Dilution | |
| ELISA | 1:500-1000 |
Frequently asked questions
Which applications is CBX2 Polyclonal Antibody (bs-53083R) validated for, and at what dilution?
bs-53083R is validated for ELISA (1:500-1000). These are recommended starting dilutions; optimal dilutions should be determined by the end user.
Which species does CBX2 Polyclonal Antibody (bs-53083R) react with?
Tested reactivity: Mouse.
How should bs-53083R be stored?
Store at -20C for 12 months. Storage buffer: 0.01M TBS(pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
What immunogen was used to raise CBX2 Polyclonal Antibody (bs-53083R)?
Polyclonal antibody raised in rabbit against mouse CBX2 (chromobox homolog 2) using two KLH-conjugated synthetic peptides containing a sequence from the central region of the protein